Food And Drug Administration

Kennedy's War On Food Dyes Could Be Coming To Your Breakfast Table
Ispire And IKE Tech Advance FDA-Backed Age Verification Tech To Curb Youth Vaping
Healthcare Workers Back Psychedelics But Lack Crucial Knowledge, Study Finds
Ispire And IKE Tech Advance FDA-Backed Age Verification Tech To Curb Youth Vaping
Healthcare Workers Back Psychedelics But Lack Crucial Knowledge, Study Finds
Massachusetts Votes Down Psychedelic Therapy After Hard-Fought Legalization Campaign, What's Next?
FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care

Food And Drug Administration Recent News

Veterans Affairs Eyes Funding For New MDMA-PTSD Trial After FDA Setback
The VA may fund a new Phase III trial for MDMA therapy to treat PTSD after the FDA rejected Lykos Therapeutics' initial application.
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Robert Kennedy Jr: Trump Wants Him To Help Pick CDC, FDA, and NIH Leaders — 'Unravel The Capture Of Agencies By Corrupt Influence'
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
MAPS shifts focus to state-level MDMA therapy legalization after FDA denial, advocating for ballot measures in states like Colorado, Oregon, and Massachusetts.
Moxy: The Short, Intense Psychedelic High Sweeping The Globe
Moxy, a powerful psychedelic, is gaining global momentum. With new FDA approved trials investigating its potential to treat mental health conditions, Moxy is poised to become a key player in the psychedelic space.
Regeneron Faces Setback With FDA Rejection Of Blood-Cancer Treatment
Regeneron Pharmaceuticals Inc. has received a setback as the Food and Drug Administration has declined its application for a blood cancer treatment.
MDMA Therapy Papers Retracted Amid Ethical Concerns At Lykos Study Site
Psychopharmacology retracts MDMA therapy papers due to ethical misconduct, while Lykos Therapeutics faces FDA rejection for PTSD treatment application.
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
The FDA is set to decide on MDMA therapy for PTSD, a move that could revolutionize treatment for veterans and others with severe trauma. Here's what's at stake
Senators Press FDA To Approve MDMA As PTSD Treatment, Stressing US Vets' Suicide Rates As Aug 11 Decision Looms
Bipartisan senators urge FDA to rely on scientific evidence in approving MDMA-Assisted Therapy for PTSD, highlighting its potential to help veterans.
FDA Accuses Companies Of Marketing Cannabis Products To Children Amid Debate On Hemp Cannabinoids Ban
FDA and FTC crack down on misleading hemp product marketing as Congress debates a nationwide ban on consumable hemp-derived cannabinoids.
Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report
The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following a critical inspection report by the Food and Drug Administration.
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
FDA and Reagan-Udall Foundation are hosting a virtual public meeting on psychedelic research titled Advancing Psychedelic Clinical Study Design, which aims to explore empirical approaches to address issues in drug development.
35 Cannabis Innovators To Watch In 2024: Leaders Shaping The Green Revolution
Discover the stories and future prospects of 35 influential figures in the cannabis industry, driving innovation and shaping the evolving landscape.
EXCLUSIVE: FDA Advisors Say Regulatory Certainty Needed For Cannabis Market
The cannabis sector is excited for several major catalysts that could help provide momentum after setbacks.
Congressional Research Service Foresees Potential DEA Endorsement Of Marijuana Rescheduling
On August 29, 2023, the U.S.
Logan Paul's PRIME Energy Drink Answers Chuck Schumer's Call For An FDA Investigation
Logan Paul's PRIME, the YouTuber's popular energy drink, has responded to Senate Majority Leader Chuck Schumer's call for an FDA investigation into PRIME.
Chuck Schumer Calls For FDA Probe Into YouTube Star Logan Paul's Energy Drink: 'Beware...An Eye Popping Level Of Caffeine'
Supreme Court Allows Abortion Pill To Stay On The Market
The U.S. Supreme Court has halted a Texas judge's restrictions on a widely used abortion pill, allowing it to remain on the market. 
Judge Halts FDA Approval Of Abortion Pill, Biden Administration Vows To Fight
A U.S. judge in Texas has suspended the government's decades-old approval of the abortion pill mifepristone, which terminates a pregnancy within the first 10 weeks.
Hot Hemp Synthetic Cannabinoids: A Threat To Utah's Medical Cannabis Industry?
The medical cannabis industry in Utah is confusing since synthetic cannabinoid-laden products appeared in naturally abundant amounts on dispensary shelves. According to the FDA, CBD is synthesized from delta-8, THC and a variety of other cannabinoids that could pose "serious health risks."
What Is The Role Of The FDA In Measures Taken By Hawaii Officials Against A CBD Company?
The Hawaii Department of Health (DOH) and Hawaii Department of Public Safety (PSD) conducted operations to execute search warrants and to embargo products at several retail stores including a CBD dispensary in Honolulu, reported
Could Biden Extinguish Tobacco Stocks With This Regulation?
The U.S. government could be speeding up a plan to ban menthol cigarettes, according to a new report. Here’s the new timeline and two stocks that could be affected.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved